Fulgent Genetics (FLGT) Total Liabilities (2015 - 2026)

Fulgent Genetics has reported Total Liabilities for 12 years, with the latest figure at $93.2 million in Q2 2026.

• Quarterly Total Liabilities rose 5.71% year-over-year to $93.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $93.2 million (up 5.71% YoY) and the FY2025 annual result came in at $106.8 million, up 17.63% from the prior year.
• Total Liabilities fell to $93.2 million in Q2 2026 per FLGT's latest filing, from $112.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $152.6 million in Q1 2022 and troughed at $83.0 million in Q1 2025.
• A 5-year average of $106.4 million and a median of $102.6 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2026: Total Liabilities plunged 39.54% in 2023, then surged 35.24% in 2026.
• Over 5 years, Total Liabilities stood at $116.2 million in 2022, then declined by 12.17% to $102.0 million in 2023, then decreased by 11.01% to $90.8 million in 2024, then grew by 17.63% to $106.8 million in 2025, then fell by 12.71% to $93.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $93.2 million, $112.2 million, and $106.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.